Adalimumab injection

Adalimumab injection is a prescription medication that belongs to a class of drugs called TNF blockers. It is used to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis. Adalimumab works by blocking the action of TNF (tumor necrosis factor), a protein that plays a role in inflammation. By reducing inflammation, adalimumab can relieve symptoms such as joint pain, swelling, and stiffness, as well as improve quality of life.

The dosage of adalimumab will depend on the specific condition being treated and the patient's individual needs and medical history. It is usually given as a subcutaneous injection (under the skin) once every 1-2 weeks. The injection can be self-administered by the patient or given by a healthcare provider. Common side effects of adalimumab may include injection site reactions (such as pain, redness, and swelling), headache, nausea, and upper respiratory tract infections.